Medivir Refocuses its Pipeline via Tibotec Deals
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 74 (Table of Contents)
Published: 1 Aug-2006
DOI: 10.3833/pdr.v2006.i74.473 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
On the last day of June 2006, small Swedish drug development company Medivir announced two new deals with Ireland-based Johnson & Johnson subsidiary Tibotec Pharmaceuticals and the extension of a 2004 agreement with the same partner...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS